NCI Director reassures on funding strength for cancer research, indicating continued support for emerging investigators.
During his address and "fireside chat" at the American Association for Cancer Research Annual Meeting 2026 in San Diego, CA, on April 20, NCI Director Anthony Letai, MD, PhD, assured the cancer community that federal support for cancer research remains strong despite numerous challenges researchers encountered during fiscal year 2025, clarified approaches to funding, and offered encouragement to early-career investigators.
No takes yet. Share an insight, caveat, or question.
A 2026 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: